ArticleCureus2025
Community Understanding and Attitudes Toward Prostate-Specific Antigen (PSA) Testing for Prostate Cancer Screening: A Cross-Sectional Survey Study From Saudi Arabia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProstate cancer (PC) significantly impacts men's health globally, including in Saudi Arabia. This study evaluates public awareness of prostate-specific antigen (PSA) testing, identifies barriers to screening participation, and explores factors influencing knowledge levels in Al Ahsa, Saudi Arabia.
methodsA cross-sectional, self-administered electronic survey was conducted among 388 participants. Convenience sampling was utilized within a population of approximately 1.3 million. The Arabic questionnaire, adapted from a prior study, assessed demographic data, knowledge, and attitudes toward PC and PSA screening. Statistical analysis included descriptive statistics and chi-square or Fisher's exact tests, with significance set at p<0.05.
resultsMost respondents were aged 18-28 (75.3%, 292 participants), unmarried (71.6%, 278 participants), and possessed bachelor's degrees (48.7%, 189 participants). Although 62.4% (242 participants) recognized PC as the most common malignancy in men, only 29.1% (113 participants) were aware of PSA testing. A mere 5.9% (23 participants) had previously undergone PSA testing, despite 57.4% (223 participants) acknowledging age over 50 as a risk factor. Notably, 93.3% (362 participants) had never sought medical assistance for prostate issues, with 79.9% (310 participants) expressing the need for additional information. Employment status and educational attainment significantly influenced knowledge levels (p=0.004 and p=0.003).
conclusionThere is a substantial lack of knowledge and awareness about PC and PSA screening among Saudi participants. Barriers include low perceived risk and fear of diagnosis, compounded by reliance on informal sources such as social media. Addressing these gaps through targeted education and proactive outreach initiatives is crucial for enhancing awareness and encouraging early screening behaviors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.